PH receives 1.4 million more ADB loan-procured COVID vaccine doses | Inquirer News
Close  

PH receives 1.4 million more ADB loan-procured COVID vaccine doses

/ 12:45 PM December 24, 2021
FILE Arrival of government procured COVID-19 vaccines. Image from NTF Against COVID-19 / Facebook

FILE Arrival of government procured COVID-19 vaccines. Image from NTF Against COVID-19 / Facebook

MANILA, Philippines — The Philippines received its procurement of some 1.4 million additional Pfizer COVID-19 vaccine doses early Friday.

The government purchased the 1,405,170 doses through a loan from the Asian Development Bank, the National Task Force Against COVID-19 said.

ADVERTISEMENT

The aircraft that transported the anti-COVID shots landed at the Ninoy Aquino International Airport Terminal 1.

On Thursday, 2,730,780 Pfizer vaccine doses, also bought by the government, were delivered in the country.

FEATURED STORIES

Of the around 192 million various COVID-19 vaccines that have arrived in the country since February, 104 million have already been injected.

Around 46.3 million individuals in the country are fully vaccinated against COVID-19 as of December 22.

The government is targeting to fully immunize 54 million people by year end to achieve population protection.

EDV

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Asian development bank, coronavirus vaccines, government loans, NTF against COVID-19, Pfizer
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.